Priya Kothapalli, MD
Interventional Cardiology · Houston, TXNPI 1780062158
Payments from drug & device makers
Across 91 payments — averaging $219.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$8K
- Heartflow, Inc.$4K
- Boston Scientific$3K
- Abiomed$2K
- Edwards Lifesciences$1K
- Medtronic$665
- plus $1K from 9 others
What the payments were for
- Consulting fees$1,8009%
- Speaking & faculty fees$1,8009%
- Grants$6,16731%
- Travel & lodging$3,48817%
- Food & beverage$6,51333%
- Education$2111%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 24 | $8,072 |
| Heartflow, Inc. | 3 | $3,749 |
| Boston Scientific | 12 | $2,751 |
| Abiomed | 10 | $2,059 |
| Edwards Lifesciences | 8 | $1,274 |
| Medtronic(2 entities) | 8 | $665 |
| Inari Medical, Inc. | 4 | $331 |
| Shockwave Medical, Inc | 2 | $231 |
| Philips North America LLC | 10 | $219 |
| Cardiva Medical, Inc. | 1 | $134 |
| Cardiovascular Systems Inc. | 2 | $132 |
| Amgen | 1 | $129 |
| Terumo Medical Corporation | 4 | $123 |
| Lantheus Medical Imaging, Inc. | 1 | $64 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $46 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FFRct$3,749
- Impella$1,824
- Ensite Cardiac Mapping System$920
- SAPIEN 3 Ultra RESILIA$682
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$316
- Optis Coronary Imaging System$281
- CoreValve Evolut$220
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$179
- HawkOne$164
- GENERAL - THERAPIES$145
- FLOWTRIEVER CATHETER, S$145
- CT THROMBECTOMY SYSTEM KIT$145
- OptoWire$134
- Repatha$129
- ELUVIA$125
- 3F$125
- PressureWire FFR$124
- Edwards SAPIEN 3 Transcatheter Heart Valve$111
- GENERAL - STENTS$100
How this compares
$19,978 in reported general payments places this provider in the 65th percentile of 686 interventional cardiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $12,028 |
| XareltoRivaroxaban | 13 | $10,853 |
| BrilintaTicagrelor | 14 | $9,065 |
| Nitroglycerin | 23 | $222 |
| Rosuvastatin Calcium | 14 | $139 |
| Metoprolol Succinate | 15 | $127 |
| Lisinopril | 13 | $35 |
| Metoprolol Tartrate | 11 | $28 |
| Atorvastatin Calcium | 11 | $18 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Houston
- Neal KleimanHouston$4.8M
- Juan GranadaHouston$4.3M
- Abhijeet DhobleHouston$2.7M
- John IsaacHouston$1.8M
- Amir KashaniHouston$1.3M
- Biswajit KarHouston$785K
- Michele SartoriHouston$603K
- Guilherme SilvaHouston$516K
- Sachin KumarHouston$446K
- Marwan JumeanHouston$427K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.